Skip to content

GENZYME BELGIUM

Absorbed by Sanofi-Aventis Belgium NV on 01-05-2012 KBO/BCE: BE 0453.475.493 subsidiary of .

Lifetime

10 annual accounts with figures on one time axis, 18 filings since 1994
peak of €29.6m in 2011
€29.6m▲ 11.3%
peak of €845,406 in 2008
€753,049▲ 20.1%
peak of €4.7m in 2010
€3.1m▼ 33.0%
€7.0m▲ 26.0%
peak of 45.3 FTE in 2010
38.2 FTE▼ 15.7%
Board12 names since 2011
1 director
Owners
consolidates
Documentsfilings and deeds
10-07-2012filed
2011financial year
Staff from 45.3 FTE to 38.2 FTE3 directors appointed, 3 resignations 25-05Equity from €4.7m to €3.1mDebts from €5.5m to €7.0m

Key points

from the 2011 annual accounts, the last ones filed

Equity

€3.1m ▼ 33.0%
4.72010+0.8Profit-2.3Dividend3.12011

GENZYME BELGIUM paid out €2.3m in dividends. That is 305% of the 2011 profit.

Payment terms

138 days from customers
Customers
115 to 138

Customers pay 23 days later.

Filings

18 annual accounts since 1994
AprilJune31 JulyOctober1995200020052010

Four of the last ten came late. The 2003 accounts came in latest, 286 days after the end of the period.

Board and ownership

last known board
Director, until 2012
Manager, last mentioned in 2012
Manager, last mentioned in 2012
Manager, last mentioned in 2012
Manager, last mentioned in 2012
Managing director, last mentioned in 2012
and 2 others
  • consolidatesannual accounts 2011
Board & ownership

Recent changes

Merger: absorbed by SANOFI-AVENTIS BELGIUM Capital €1,162,500, annual accounts 2011 · Gazette deed
, , and change roles holds all the shares · Legal-form conversion: from public limited company to private limited company (pre-2019) · Capital of €1,162,500, 23,250 shares · Gazette deed
2 directors appointed, 2 resignations and resign · and appointed · General meeting of 20-01-2012 · Gazette deed
New managing director appointed, resigned · Board meeting of 23-01-2012 · Gazette deed
All 31 events

Official details

Source: KBO
Status
Absorbed by Sanofi-Aventis Belgium NVmerger by absorption, May 2012
Activity
“Het verlenen van diensten van allerlei aard;” (deed in Dutch)From the articles, 5 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2011

€12.5m▲ 21.8%
Filing
Filed on 10-07-2012
Financials

Insights on GENZYME BELGIUM

Absorbed by Sanofi-Aventis Belgium NV in May 2012. The last annual accounts are for financial year 2011.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GENZYME BELGIUM

What is the company number of GENZYME BELGIUM?
The company number of GENZYME BELGIUM is 0453.475.493. The VAT number is the same number with BE in front: BE 0453.475.493.
What is the legal form of GENZYME BELGIUM?
Legal form of GENZYME BELGIUM: BVBA.
Is GENZYME BELGIUM still active?
No. Absorbed in a merger on 01-05-2012.Company details
How many employees did GENZYME BELGIUM have?
GENZYME BELGIUM had an average of 38.2 full-time equivalents in financial year 2011, according to the filed annual accounts.Financials
What is the turnover of GENZYME BELGIUM?
The turnover of GENZYME BELGIUM was €29.6m in financial year 2011, according to the filed annual accounts.
Is GENZYME BELGIUM profitable?
In financial year 2011, GENZYME BELGIUM made a profit of €753,049.
Where can I find the annual accounts of GENZYME BELGIUM?
GENZYME BELGIUM filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2011.

Next steps

Keep this company with today's facts in a case file.